CRYSTAL MAXWELL: Open Payments
NPI 1821750274 · COOKEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,081 in 48 payments from 11 companies in 2025. Trend: 2023 $1,480 · 2024 $1,724 · 2025 $1,081
Food & beverage: $1,081
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $289 |
| Neurocrine BioSciences, Inc. | 7 | $172 |
| Corium, LLC | 8 | $165 |
| E.R. Squibb & Sons, L.L.C. | 5 | $163 |
| Alkermes, Inc. | 4 | $89 |
| ABBVIE INC. | 4 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
Products named: AUSTEDO XR, INGREZZA, Azstarys, COBENFY, VRAYLAR, ARISTADA, LYBALVI, HETLIOZ.
Industry payments across TN — which companies pay providers there.
